EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.

已完结 20 由呵呵哒发布于 2026/9/14 11:07:51

DOI:10.1158/0008-5472.can-25-4582
作者：Huiying Gu,Fan Li,Yuyan Chen,Mengling Zhang,Qiumin Wu,Haibei Zhao,Chongyang Zhou,Li Yan,Ruixi Xie,Xinchang Huang,Jihua Ren,Shengtao Cheng,Haibo Yu,Yong Chen,Zhenzhen Zhang,Juan Chen
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1158/0008-5472.can-25-4582

American Association for Cancer Research (AACR)

Abstract：The clinical efficacy of lenvatinib, a multitarget tyrosine kinase inhibitor used as a first-line treatment for advanced hepatocellular carcinoma (HCC), is frequently compromised by the deve

应助信息

1天前

yong19

e8f133a0afea11f18d1534735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/9/14 11:07:51 未找到该文献，机器人已退出，请等待人工下载

2026/9/14 11:07:51 Book学术AI机器人收到请求，开始寻找文献

2026/9/14 11:07:51 已向机器人发送请求

1天前

呵呵哒发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Emerging drug delivery system to the brain: using extracellular vesicles and liposomes hybrid platform